πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

211 results for β€œJian” Clear

  1. HEC113995PAβ€’H2O tablet

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  2. HEC116094

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Influenza

    phase 1 small molecule completed

    1 trial

  3. HEC122505MsOH

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Parkinson Disease

    phase 1 small molecule completed

    1 trial

  4. HEC169584 capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Non - Alcoholic Steatohepatitis

    phase 1 small molecule active

    1 trial

  5. HEC30654AcOH capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  6. HEC53856

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Hemodialysis

    phase 1 small molecule completed

    1 trial

  7. HEC53856

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Kidney Diseases

    phase 1 small molecule completed

    1 trial

  8. HEC53856

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  9. HEC68498

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Refractory Solid Tumors

    phase 1 small molecule completed

    1 trial

  10. HEC73077 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetic Nephropathy

    phase 1 small molecule completed

    1 trial

  11. HEC74647

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  12. HEC74647PA capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis C

    phase 1 small molecule completed

    2 trials

  13. HEC83518

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Insomnia

    phase 1 small molecule completed

    1 trial

  14. HEC83518 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Insomnia

    phase 1 small molecule completed

    1 trial

  15. HEC89736

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Relapsed or Refractory B-cell Hematologic Malignancies

    phase 1 small molecule terminated

    1 trial

  16. HEC93077

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Gout

    phase 1 small molecule completed

    1 trial

  17. HEC96719

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  18. HEC96719

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Non-alcoholic Fatty Liver Disease

    phase 1 small molecule completed

    1 trial

  19. HEC96719 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  20. HRS-2329 Tablet

    Jian Li

    Advanced Solid Tumors Harboring RAS Mutations or Amplifications

    phase 1 small molecule active

    1 trial

  21. HS-10345 84mg

    Jian Li

    Treatment Resistant Depressive Disorder

    phase 1 small molecule completed

    1 trial

  22. HS-10382(Part 1: Dose escalation)

    Jian Li

    CML, Chronic Phase

    phase 1 small molecule active

    1 trial

  23. Humanized TNFΞ± monoclonal antibody

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial

  24. Insulin degludec injection, RD15003

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Type 2 Diabetes

    phase 1 mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources